Introduction {#s1}
============

Methicillin-resistant *Staphylococcus aureus* (MRSA) is still a leading pathogen of nosocomial infections in China. Because of its ability to produce virulence factors causing a variety of infections and its serious multidrug resistance, MRSA is one of the most frightening bacteria.

The pathogenesis of *S. aureus* infections is involved in the expression of a wide range of virulence factors associated with attachment, persistence, evading/destroying host defenses, tissue invasion/penetration and toxin**-**mediated disease [@pone.0037005-Gordon1]. However, a majority of the serious *S. aureus* infections are caused by the combined actions of several virulence factors. Otherwise, clinical isolates linked to *S. aureus* infection may be naturally deficient in a scale of putative pathogenic determinants. Therefore, strains causing *S. aureus* disease have variable combinations of virulence genes [@pone.0037005-Peacock1].

Mupirocin is a very effective topical antibiotic used to treat staphylococcal skin and soft tissue infections and eliminate MRSA from colonized nasal passages. However, the resistance to mupirocin has occurred, and its spreading is worrisome, with *mupA* **-**mediated high**-**level resistance [@pone.0037005-PrezRoth1]. The *mupA* gene is usually located on a large conjugative plasmid capable of mediating the co-transfer of other resistance genes. If high-level mupirocin resistance could not be controled, a highly effective means of decolonization of MRSA may be lost. Thus the high-level mupirocin resistance MRSA (MuH MRSA) may spread widely, and causes a range of infections. Therefore it is necessary to know the traits of virulence of clinical MuH MRSA strains more comprehensively.

The purpose of this study was to investigate the prevalence of putative virulence genes in a clinical population of MuH MRSA isolates with known types of PFGE-SCC*mec*-*spa* from two different geographic areas in China, and explore the possible difference in virulence determinants combination between the strains from the both origins. Finally we further determined the genetic characteristics of these isolates by *agr* (accessory gene regulator) typing and multilocus sequence typing (MLST).

Materials and Methods {#s2}
=====================

MuH MRSA Isolates {#s2a}
-----------------

Fifty three MuH MRSA isolates were selected from 5 university hospitals collection in Shanghai (n = 28, 4 hospitals) and Wenzhou (n = 25, 1 hospital), China. This collection comprised 803 MRSA, which were isolated from various clinical specimens of individual inpatients from August 2005 to May 2008. Most of the MuH isolates were gathered from respiratory samples (86.8%). Intensive care units, surgical wards, burn wards and neurology wards were the major hospital units affected by MuH MRSA. All isolates had been previously described by PFGE, SCC*mec* and *spa* typing and these results are shown in [Table 1](#pone-0037005-t001){ref-type="table"} [@pone.0037005-Liu1]. Because of being focused on bacteria, this study was exempted from review by the Ethics Committee of Shanghai First People's Hospital.

10.1371/journal.pone.0037005.t001

###### The PFGE-SCC*mec-spa* patterns of 53 MuH MRSA isolates [@pone.0037005-Liu1].

![](pone.0037005.t001){#pone-0037005-t001-1}

  PFGE-SCC*mec-spa*type    No. of isolates (n)   Originationof isolates   PFGE-SCC*mec-spa*type   No. ofisolates (n)   Originationof isolates
  ----------------------- --------------------- ------------------------ ----------------------- -------------------- ------------------------
  A1-IIIA-t030                     12                   Wenzhou                I-III-t037                 3                   Shanghai
  A2-IIIA-t030                      4                   Wenzhou                 J-I-t189                  1                   Wenzhou
  A3-IIIA-t030                      1                   Wenzhou             K-III-nontypeable             1                   Shanghai
  A4-IIIA-t030                      1                   Wenzhou                L1-II-t002                 1                   Shanghai
  A5-IIIA-t037                      2                   Shanghai               L2-III-t002                1                   Shanghai
  B-IIIA-t030                       4                   Wenzhou               M1-IIIA-t002                2                   Shanghai
  C-IIIB-t037                       1                   Shanghai              M2-IIIA-t002                1                   Shanghai
  D1-IIIA-t037                      1                   Shanghai                N-I-t318                  5                   Shanghai
  D2-IIIA-t037                      1                   Shanghai                N-IA-t318                 1                   Shanghai
  E-IIIA-t127                       1                   Shanghai               O-III-t377                 1                   Shanghai
  F1-II-t002                        1                   Shanghai               P1-III-t037                2                   Shanghai
  F2-II-t002                        1                   Shanghai               P2-III-t037                1                   Shanghai
  G-IIIA-t030                       1                   Wenzhou                Q-IIIA-t985                1                   Shanghai
  H-IIIA-t2505                      1                   Wenzhou                                                       

Detection of Virulence Factor Genes and *agr* Alleles {#s2b}
-----------------------------------------------------

Genomic DNA from MuH MRSA was extracted by the bacterial genomic DNA kit (Wuxi Institution of Clone and Genetic Technology, China) and then used for PCR amplification of 35 virulence genes (involved in toxin mediated disease, attachment, evading/destroying host defenses, tissue invasion/penetration, persistence and others) and *agr* alleles (allele *1* to *4*) by the primers derived from the published sequences [@pone.0037005-Peacock1], [@pone.0037005-Jarraud1]-[@pone.0037005-Cafiso1]. These genes were all listed in [Table 2](#pone-0037005-t002){ref-type="table"}.

10.1371/journal.pone.0037005.t002

###### The genes detected by PCR in this investigation.

![](pone.0037005.t002){#pone-0037005-t002-2}

  Virulence gene                                                                                                         Reference                             Virulence gene                             Reference
  --------------------------------------------------------------------------------------------------------------------- ----------- -------------------------------------------------------------------- -----------
  Involved in toxin mediated disease and/or sepsis                                                                                             Capsular polysaccharide 5, 8 (*cap5*, *cap8*)                  9
  Staphylococcal enterotoxin A, B, C, D, E, G, H, I, J(*sea*, *seb*, *sec*, *sed*, *see*, *seg*, *seh*, *sei*, *sej*)      5,6,7     Major-histocompatibility-complex class II-analogue protein (*map*)       2
  Exfoliative toxin A, B (*eta*, *etb*)                                                                                      5                      IgG**-**binding protein SBI (*sbi*)                      10
  α, β, δ-hemolysin (*hla*, *hlb*, *hld*)                                                                                    5                    Involved in tissue invasion/penetration                
  Toxic shock syndrome toxin-1 (*tst*)                                                                                       6                           V8 serine protease (*ssp*)                          10
  Involved in attachment                                                                                                                                   Staphylokinase (*sak*)                            11
  Fibronectin-binding protein A, B (*fnbA*, *fnbB*)                                                                         2,8                           Involved in persistence                        
  Clumping factor A,B (*clfA*, *clfB*)                                                                                       2                  Intercellular adhesion A, D (*icaA*, *icaD*)                 12
  Collagen adhesin (*cna*)                                                                                                   2                                     Others                                
  Bone sialoprotein**-**binding protein (*bbp*)                                                                              2                 Staphylococcal accessory regulator A (*sarA*)                 10
  Elastin-binding protein (*ebpS*)                                                                                           2              Extracellular fibrinogen**-**binding protein (*efb*)             10
  Involved in evading/destroying host defenses                                                                                       * arcA* region of arginine catabolic mobile element (ACME-*arcA*)       13
  Panton-Valentine leukocidin (*pvl*)                                                                                        5                                 *agr* alleles                             
  γ-hemolysin and variant (*hlg*, *hlgv*)                                                                                    5                               allele *1* to *4*                               14

DNA Sequencing {#s2c}
--------------

One randomly chosen amplicon for the each gene tested was sequenced on an ABI 3730 sequencer (Applied Biosystems) by Shanghai Invitrogen Biotech to confirm that primers amplified the expected genes.

MLST {#s2d}
----

MLST was performed on 27 MuH MRSA isolates representative of each PFGE-SCC*mec*-*spa* type as described previously [@pone.0037005-Enright1]. Sequence type (ST) of each strain was determined by sequencing internal fragments of 7 housekeeping genes (*arcC*, *aroE*, *glpF*, *gmk*, *pta*, *tp*i and *yqiL*) according to the MLST database (<http://www.mlst.net>).

Statistical Analyses {#s2e}
--------------------

Pearson's chi-square test or Fisher's exact test if necessary was used to compare distribution of the virulence determinants in clinical MuH MRSA strains investigated (SPSS version11.5). All statistical tests were two tailed, with *P*\<0.05 considered statistically significant.

Results {#s3}
=======

Comparison of Virulence Genes in Shanghai and Wenzhou Isolates {#s3a}
--------------------------------------------------------------

Compared to Wenzhou isolates, Shanghai strains were significantly less likely to contain *sea* (32.1% versus 80.0%, *P*\<0.001), *cna* (67.9% versus 92.0%, *P* = 0.031) and *efb* (64.3% versus 88.0%, *P* = 0.045), and more likely to host *seg* (57.1% versus 16.0%, *P* = 0.002). For Shanghai strains, 42.9%, 53.6%, 50.0%, 7.1% and 28.6% carried *sec*, *sei*, *tst*, *sej* and *pvl*, respectively, whereas no isolate from Wenzhou possessed them, and those differences except that of *sej* were significant. No isolate from either origin was positive for *seb*, *sed*, *see*, *seh*, *eta*, *etb*, *hld*, *cap-5* and *ACME*-*arcA* ([Table 3](#pone-0037005-t003){ref-type="table"}). The distribution of the remaining virulence genes in 53 MuH MRSA isolates were summarized in [Table 3](#pone-0037005-t003){ref-type="table"}.

10.1371/journal.pone.0037005.t003

###### Distribution of 35 virulence genes among the isolates of MuH MRSA from Shanghai and Wenzhou, China.

![](pone.0037005.t003){#pone-0037005-t003-3}

  Gene                                                No. of isolates positive for the gene \[% of total (n = 53)\]   No.of isolates positive for the gene in two regions (%)   χ^2^ (*P* value)  
  -------------------------------------------------- --------------------------------------------------------------- --------------------------------------------------------- ------------------ ------------------------------------------
  Involved in toxin mediated disease and/or sepsis                                                                                                                                                
  *sea*                                                                         29 (54.7)                                                    9 (32.1)                              20 (80.0)                   12.208 (\<0.001)
  *seb*                                                                             0                                                            0                                     0                              NA
  *sec*                                                                         12 (22.6)                                                    12 (42.9)                                 0                       13.850 (\<0.001)
  *sed*                                                                             0                                                            0                                     0                              NA
  *see*                                                                             0                                                            0                                     0                              NA
  *seg*                                                                         20(37.7)                                                     16 (57.1)                              4 (16.0)                    9.515 (0.002)
  *seh*                                                                             0                                                            0                                     0                              NA
  *sei*                                                                         15 (28.3)                                                    15 (53.6)                                 0                       18.680 (\<0.001)
  *sej*                                                                          2 (3.8)                                                      2 (7.1)                                  0           (0.492)[\*](#nt103){ref-type="table-fn"}
  *tst*                                                                         14 (26.4)                                                    14 (50.0)                                 0                       16.987 (\<0.001)
  *eta*                                                                             0                                                            0                                     0                              NA
  *etb*                                                                             0                                                            0                                     0                              NA
  *hla*                                                                         52 (98.1)                                                    27 (96.4)                              25 (100)       (1.000)[\*](#nt103){ref-type="table-fn"}
  *hlb*                                                                         43 (81.1)                                                    21 (75.0)                             22 (88.0)                    0.733 (0.392)
  *hld*                                                                             0                                                            0                                     0                              NA
  Involved in attachment                                                                                                                                                                          
  *fnbA*                                                                        48 (90.6)                                                    26 (92.9)                             22 (88.0)                    0.018 (0.894)
  *fnbB*                                                                        8 (15.1)                                                     7 (25.0)                               1 (4.0)                     3.045 (0.081)
  *clfA*                                                                        41 (77.4)                                                    21 (75.0)                             20 (80.0)                    0.189 (0.664)
  *clfB*                                                                        52 (98.1)                                                    27 (96.4)                              25 (100)       (1.000)[\*](#nt103){ref-type="table-fn"}
  *cna*                                                                         42 (79.2)                                                    19 (67.9)                             23 (92.0)                    4.681 (0.031)
  *bbp*                                                                         7 (13.2)                                                     6 (21.4)                               1 (4.0)                     2.145 (0.143)
  *ebpS*                                                                        50 (94.3)                                                    27 (96.4)                             23 (92.0)                    0.010 (0.919)
  Involved in evading/destroying host defenses                                                                                                                                                    
  *pvl*                                                                         8 (15.1)                                                     8 (28.6)                                  0                        6.331 (0.012)
  *hlg*                                                                         46 (86.8)                                                    22 (78.6)                             24 (96.0)                    2.145 (0.143)
  *hlgv*                                                                        7 (13.2)                                                     6 (21.4)                               1 (4.0)                     2.145 (0.143)
  *cap-5*                                                                           0                                                            0                                     0                              NA
  *cap-8*                                                                       48 (90.6)                                                    23 (82.1)                              25 (100)                    3.061 (0.080)
  *map*                                                                         44 (83.0)                                                    23 (82.1)                             21 (84.0)                    0.000 (1.000)
  *sbi*                                                                         51 (96.2)                                                    28 (100)                              23 (92.0)       (0.218)[\*](#nt103){ref-type="table-fn"}
  Involved in tissue invasion/penetration                                                                                                                                                         
  *ssp*                                                                         46 (86.8)                                                    23 (82.1)                             23 (92.0)                    0.425 (0.515)
  *sak*                                                                         45 (84.9)                                                    21 (75.0)                             24 (96.0)                    3.054 (0.081)
  Involved in persistence                                                                                                                                                                         
  *icaA*                                                                        43 (81.1)                                                    21 (75.0)                             22 (88.0)                    0.733 (0.392)
  *icaD*                                                                        53 (100)                                                     28 (100)                               25 (100)                          NA
  Others                                                                                                                                                                                          
  *sarA*                                                                        46 (86.8)                                                    24 (85.7)                             22 (88.0)                    0.000 (1.000)
  *efb*                                                                         40 (75.5)                                                    18 (64.3)                             22 (88.0)                    4.012 (0.045)
  *ACME*-*arcA*                                                                     0                                                            0                                     0                              NA

*P*\<0.05 were considered statistically significant.

NA, not available.

Fisher's exact test.

Virulence Genes Content and Combination in Shanghai and Wenzhou Isolates {#s3b}
------------------------------------------------------------------------

Of 28 Shanghai strains, 13 (46.4%) possessed ≥5 virulence genes involved in toxin mediated disease (high toxin gene content), however, no Wenzhou strain carried ≥5 this type of genes. The most prevalent combination of this type of genes was *hla*+*hlb*+*seg*+*sei*+*tst*+*sec* (25.0% of strains, 7/28) in Shanghai strains. And the second frequent combination was *sea*+*hla*+*hlb* (17.9% of strains, 5/28), which was also the most main combination in Wenzhou strains (68.0% of strains, 17/25) ([Table 4](#pone-0037005-t004){ref-type="table"}). As for the adhesion determinants, 17 (60.7%) Shanghai isolates and 20 (80.0%) Wenzhou isolates possessed ≥5 genes. The combinations of *fnbA*+*clfA*+*clfB*+*ebpS*+*bbp*+*cna* and *fnbA*+*clfA*+*clfB*+*ebpS*+*cna* were overrepresented in Shanghai (21.4%, 6/28) and Wenzhou strains (76.0%, 19/25), respectively ([Table 4](#pone-0037005-t004){ref-type="table"}). As indicated in [Table 4](#pone-0037005-t004){ref-type="table"}, there were 8 (28.6%, 8/28) Shanghai iaolates harboring the pattern of *hlg*+*sbi*+*cap-8*+*map*+*pvl*, and 20 (80.0%, 20/25) Wenzhou isolates containing the combination of *hlg/hlgv*+*sbi*+*cap-8*+*map*. However, no Wenzhou strain hosted ≥5 this kind of determinants. The other combination of virulence genes were shown in [Table 4](#pone-0037005-t004){ref-type="table"}.

10.1371/journal.pone.0037005.t004

###### Virulence gene profile and genetic characteristics of 53 MuH MRSA isolates from Shanghai and Wenzhzou, China.

![](pone.0037005.t004){#pone-0037005-t004-4}

  Strain                                  Virulence gene profile                               *agr*type                     PFGE-SCC*mec*-*spa* ^\#^ [@pone.0037005-Liu1]   MLSTtype[\*](#nt104){ref-type="table-fn"}                                                   
  ---------------------------- --------------------------------------------- ---------------------------------------------- ----------------------------------------------- ------------------------------------------- -------------- ------------- ---- -------------- -------
  Shanghai strain                                                                                                                                                                                                                                                        
  1, 3, 4, 5, 6                     *hla, hlb, seg*, *sei*, *tst, sec*        *fnbA*, *clfA*, *clf*B, *ebpS*, *bbp*, *cna*          *hlg, sbi, cap-8*, *map*, *pvl*                        *ssp*, *sak*                  *icaD, icaA*     *sarA*      3      N-I-t318     ST284
  2                                 *hla, hlb, seg*, *sei*, *tst, sec*        *fnbA*, *clfA*, *clf*B, *ebpS*, *bbp*, *cna*          *hlg, sbi, cap-8*, *map*, *pvl*                        *ssp*, *sak*                  *icaD, icaA*     *sarA*      3     N-IA-t318     ST284
  7                             *hla*, *hlb, seg, sei*, *tst*, *sec*, *sej*          *fnbA*, *clfA*, *clfB*, *ebpS*                    *hlg, sbi, cap-8*, *map*                             *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1     L1-II-t002     ST5
  15                                       *hla, seg, sei, sej*                         *fnbA, clfA, clfB, ebpS*                            *hlg, sbi, map*                                    *ssp*                        *icaD*      *sarA, efb*   2    L2-III-t002     ST5
  8                                           *hla, hlb, sea*                     *fnbA, clfA, clfB, ebpS, cna, fnbB*                   *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    P2-III-t037    ST239
  9, 11                                       *hla, hlb, sea*                     *fnbA, clfA, clfB, ebpS, cna, fnbB*                   *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    P1-III-t037    ST239
  10                                               *hla*                                   *fnbA, clfB, fnbB*                           *hlgv, sbi, cap-8, map*                             *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1     O-III-t377    ST630
  12                                               *hlb*                                *fnbA, clfB, ebpS, cna*                               *hlgv, sbi*                                   *ssp, sak*                      *icaD*                    2     I-III-t037    ST239
  13                                               *hla*                                   *fnbA, ebpS, cna*                                  *hlgv, sbi*                                                                   *icaD*                    2     I-III-t037   
  14                                               *hla*                                *fnbA, clfB, ebpS, cna*                               *hlgv, sbi*                                                                   *icaD*                    2     I-III-t037   
  16                                            *hla, tst*                                   *clfB, ebpS,*                               *hlgv*, *sbi, cap-8*                                                               *icaD*                    2      K-III-nt     ST239
  17                                       *hla, hlb, seg, sei*                      *fnbA, clfA, clfB, ebpS, fnbB*                     *hlg, sbi, cap-8, map*                                 *ssp*                     *icaD, icaA*   *sarA, efb*   1    D1-IIIA-t037   ST239
  26                                            *hla, sea*                           *fnbA, clfA, clfB, ebpS, cna*                      *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    D2-IIIA-t037   ST239
  18                                  *hla, hlb, seg, sei, tst, sec*                    *fnbA, clfA, clfB, ebpS*                        *hlg, sbi, cap-8, map*                                 *ssp*                     *icaD, icaA*   *sarA, efb*   1    M2-IIIA-t002    ST5
  23                                *hla, hlb, seg, sei, tst, sec, sea*                 *clfA, clfB, ebpS, cna*                       *hlg, sbi, cap-8, map, pvl*                           *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    M1-IIIA-t002    ST5
  24                                *hla, hlb, seg, sei, tst, sec, sea*              *fnbA, clfA, clfB, ebpS, cna*                      *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    M1-IIIA-t002  
  19                                          *hla, hlb, sea*                        *fnbA, clfA, clfB, ebpS, cna*                      *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   3    E-IIIA-t127     ST1
  20                                     *hla, hlb, seg, sei, tst*                    *clfA, clfB, bbp, ebpS, cna*                         *hlg, sbi, cap-8*                                *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1     F2-II-t002     ST5
  28                                            *hla, hlb*                              *fnbA, clfA, clfB, ebpS*                            *hlg, sbi, map*                                 *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1     F1-II-t002     ST5
  21                                     *hla, hlb, seg, tst, sec*                   *fnbA, clfA, clfB, ebpS, fnbB*                   *hlg, sbi, cap-8, map, pvl*                           *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    C-IIIB-t037    ST239
  22                             *hla, hlb, seg, sei, tst, sec, sea sea,*         *fnbA, clfA, clfB, ebpS, cna, fnbB*                       *hlg, sbi, map*                                 *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    A5-IIIA-t037   ST239
  27                                          *hla, hlb, sea*                           *fnbA, clfB, ebpS, cna*                         *hlg, sbi, cap-8, map*                              *ssp, sak*                      *icaD*      *sarA, efb*   1    A5-IIIA-t037  
  25                                          *hla, seg, sei*                           *fnbA, clfB, ebpS, cna*                           *hlgv, sbi, cap-8*                                   *sak*                        *icaD*      *sarA, efb*   1    Q-IIIA-t985     ST5
  Wenzhou strain                                                                                                                                                                                                                                                         
  29                                          *hla, hlb, seg*                        *fnbA, clfB, ebpS, cna, fnbB*                      *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1      J-I-t189     ST188
  30                                               *hla*                                   *clfB, ebpS, cna*                             *hlgv*, *sbi, cap-8*                                  *ssp*                        *icaD*                    2    A1-IIIA-t030   ST239
  31, 32, 33                               *hla, hlb, sea, seg,*                     *fnbA, clfA, clfB, ebpS, cna*                      *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   11   A1-IIIA-t030  
  35, 40, 42, 43, 50, 51, 53                 *hla, hlb, sea,*                        *fnbA, clfA, clfB, ebpS, cna*                      *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    A1-IIIA-t030  
  52                                               *hla*                                   *clfB, ebpS, cna*                                 *hlg, cap-8*                                      *sak*                        *icaD*        *sarA*      2    A1-IIIA-t030  
  34                                            *hla, hlb*                              *fnbA, clfA, clfB, bbp*                            *hlg, cap-8, map*                                *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    H-IIIA-t2505   ST239
  36, 37, 38, 39                             *hla, hlb, sea,*                        *fnbA, clfA, clfB, ebpS, cna*                      *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    A2-IIIA-t030   ST239
  41, 44, 46                                 *hla, hlb, sea,*                        *fnbA, clfA, clfB, ebpS, cna*                      *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    B-IIIA-t030    ST239
  45                                               *hla*                                *fnbA, clfB, ebpS, cna*                            *hlg, sbi, cap-8*                                *ssp, sak*                      *icaD*         *efb*      2    B-IIIA-t030   
  47                                          *hla, hlb, sea*                                 *clfB, cna*                                  *hlg, sbi, cap-8*                                   *sak*                     *icaD, icaA*     *sarA*      1    A4-IIIA-t030   ST239
  48                                          *hla, hlb, sea*                        *fnbA, clfA, clfB, ebpS, cna*                      *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    G-IIIA-t030    ST239
  49                                          *hla, hlb, sea*                        *fnbA, clfA, clfB, ebpS, cna*                      *hlg, sbi, cap-8, map*                              *ssp, sak*                   *icaD, icaA*   *sarA, efb*   1    A3-IIIA-t030   ST239

MLST (multilocus sequence typing) was performed on representative isolates for each PFGE-SCC*mec*-*spa* type;

nt: nontypable; *agr*: accessory gene regulator; PFGE: pulsed-field gel electrophoresis; SCC*mec*:

staphylococcal chromosomal cassette *mec*; *spa*: staphylococcal protein A.

agr Allele Distribution {#s3c}
-----------------------

Of the 53 isolates, 38 (16 from Shanghai and 22 from Whenzhou) were *agr-1*, 8 (5 Shanghai isolates and 3 Whenzhou isolates) were *agr-2*, and 7 (all from Shanghai) were *agr-3*. None was positive for *agr-4* ([Table 4](#pone-0037005-t004){ref-type="table"}).

MLST {#s3d}
----

A total of 27 isolates representative of each PFGE-SCC*mec*-*spa* profile were studied by MLST. And six ST types such as ST239, ST5, ST630, ST1, ST284 and ST188 were generated. ST239 was the most prevalent type (55.6%, 15/27), including A1 or A2 or A3 or A4 or B or G-IIIA-t030, A5 or D1-IIIA-t037, C-IIIB-t037, A1-IIIA-t2505, H-IIIA-t030, I or P1 or P2-III-t037, K-III-nt and L2-III-t002. The association between the other 5 ST types and PFGE-SCC*mec*-*spa* types were displayed in [Table 4](#pone-0037005-t004){ref-type="table"}.

Discussion {#s4}
==========

*S. aureus* produces numerous extracellular proteins which involve in the ability of this organism causing disease in the mammalian host. In this study, we detected six groups of pathogenic genes for 53 clinical MuH MRSA isolates from Shanghai and Wenzhou regions, China ([Table 2](#pone-0037005-t002){ref-type="table"}). The first of these were the genes involved in toxin mediated disease. Previous study showed toxins encoded by *sea* and *sec* tend to generate higher immune responses resulting in host tissue damage than do other enterotoxins [@pone.0037005-Ferry1]. However, we did not find the existence of *sec* in Wenzhou isolates. It is generally believed that the existence of the enterotoxin gene cluster (*egc*, containing *seg* and *sei*) is not related with severe infections, but probably contributes to the colonization potential of an *S. aureus* strain [@pone.0037005-Ferry1], [@pone.0037005-Holtfreter2], [@pone.0037005-VanBelkum1]. Because the toxins transcripted by the *egc* element appear to be generated in lower amounts compared to the other well-studied enterotoxins which may permit strains carrying the *egc* determinants to live together with healthy hosts [@pone.0037005-Holtfreter2]. However, Morgan's report showed the products of *egc* may play a part in some cases, especially in immuno-compromised patients [@pone.0037005-Morgan1]. Due to the genes *seg* and *sei* being located on *egc* element [@pone.0037005-Jarraud2], the combined occurrence of the toxin gene pair can generally be observed. Notably, 25.0% (5/20) *seg-*positive isolates were not confirmed with the fixed *seg*-*sei* combination in our study. The *sed* and *sej* genes are encoded by a plasmid pIB485 [@pone.0037005-Zhang1]. However, the coexistence of the two determinants cannot also be certified with 2 *sej*-positive isolates ([Table 4](#pone-0037005-t004){ref-type="table"}). The possible explanation for these opposite results is the existence of still-unknown variants of *sei* and *sed*.

The second group consisted of the determinants involved in attachment (*fnbA*, *fnbB*, *clfA*, *clfB*, *cna*, *bbp* and *ebpS*). The expression products of these genes were termed MSCRAMMs (microbial surface components recognizing adhesive matrix molecules). A great majority of our strains harbored the genes encoding FnbA, ClfA, ClfB, Cna and EbpS ([Table 3](#pone-0037005-t003){ref-type="table"}), which may make them possess the ability to bind to fibronectin, fibrinogen and fibrin [@pone.0037005-Zmantar1], collagen substrates and collagenous tissues [@pone.0037005-Patti1], and soluble tropoelastin [@pone.0037005-Downer1]. There is evidence that Bbp is a key factor in bone and joint infections produced by *S. aureus* [@pone.0037005-Hudson1], [@pone.0037005-Tung1]. However, the positive rate of *bbp* implied most MuH MRSA strains of our collection might not have the ability to cause those diseases.

The third group included the genes *pvl*, *hlg*/*hlgv*, *cap-5*, *cap-8*, *map* and *sbi*. The toxins encoded by *pvl* and *hlg* are leukotoxic for neutrophils and macrophages [@pone.0037005-Voyich1]. Capsular polysaccharide (Cap) can protect the bacterium from phagocytic uptake and increases microbial virulence. Map may potentiate *S. aureus* survival by affecting protective cellular immunity [@pone.0037005-Harraghy1], [@pone.0037005-Lee1]. Sbi has the ability to hinder phagocytosis and is implicated in blood coagulation [@pone.0037005-Atkins1]. In this study, we did not see any significant difference in the prevalence of this group of genes except *pvl* between the Shanghai and Wenzhou strains ([Table 3](#pone-0037005-t003){ref-type="table"}).

Ssp can degrade host cell receptors and/or bacterial adhesins, and promote the spread and transmission of infection [@pone.0037005-Rice1]. Sak may mediate bacterial invasion into the host tissues and enhance bacterial resistance to phagocytosis [@pone.0037005-Bokarewa1]. According to [Table 3](#pone-0037005-t003){ref-type="table"}, most of our isolates may have the functions mentioned above.

The genes *icaA* and *icaD* belong to *ica* operon (*icaADB* and *C*), which is revealed to induce polysaccharide intercellular adhesin (PIA, associated with biofilm formation) synthesis in staphylococcus. However, expression of *icaA* alone leads only to low production of PIA. It was demonstrated that coexpression of *icaA* with *icaD* will promote the biosynthesis of capsular polysaccharide [@pone.0037005-Arciola1]. In this study, a small part of our strains were negative for *icaA* ([Table 3](#pone-0037005-t003){ref-type="table"}). This phenomenon may be the deficiency of *icaA* gene or the existence of point mutations in the primer binding sites causing a negative PCR reaction.

It has been hypothesized that Efb might benefit the bacterium by interacting with fibrinogen and preventing the clotting process, thereby delaying the healing process [@pone.0037005-Palma1]. *sar* (containing 3 transcripts designated *sarA*, *sarB* and *sarC*) is a global regulatory locus, and controls the production of many virulence factors in *S. aureus*. Among which the *sarA* encodes the major effector molecule [@pone.0037005-Chien1]. *ACME* can encode an arginine deiminase pathway and an oligopeptide permease system that could enhance the ability of *S. aureus*, especially for USA300 clone, to grow and survive within the host [@pone.0037005-Diep1]. [Table 3](#pone-0037005-t003){ref-type="table"} showed the genes *efb* and *sarA* were prevalent in most our strains; however, no isolate studied possessed the founction of *ACME* gene.

*agr* is another important global regulatory locus controlling the production of most staphylococcal exoproteins. In *S*. *aureus*, four different *agr* alleles have been described and *agr* is regarded as a slowly evolving genetic marker to investigate hospital-acquired MRSA [@pone.0037005-Ghebremedhin1]. A report by Van Leeuwen et al. [@pone.0037005-VanLeeuwen1] suggested that the *agr-1* is the most prevalent *agr* group in MRSA isolates. We found similar in our isolates (71.7%, 38/53) ([Table 4](#pone-0037005-t004){ref-type="table"}) and by Liu et al. [@pone.0037005-Liu2] (96.4%, 134/139) in Beijing MRSA strains. Besides *agr-1*, 28.3% (15/53) of our strains belonged to *agr-2* or *agr-3*. Previous investigation has demonstrated the association between *agr-3* and TSST-1 [@pone.0037005-Jarraud3], whereas the findings of this study revealed that only 6 of 14 *tst*-positive strains were *agr-3*, and the remainder belonged to *agr-1* (7 isolates) and *agr-2* (1 isolates) ([Table 4](#pone-0037005-t004){ref-type="table"}). Likewise, the data reported by Ben Nejma et al. [@pone.0037005-BenNejma1] could also not reveal the relationship between *agr-3* and this toxin.

Researches based on MLST exhibited that the predominant MRSA clone was ST239-MRSA in Asian countries besides Japan and South Korea (ST5). Yu et al. [@pone.0037005-Yu1] and Yao et al. [@pone.0037005-Yao1] reported that ST239-MRSA was the most commonly detected clone in MRSA obtained from Wenzhou, and Liu et al. [@pone.0037005-Liu3] also discovered the prevalence of this clone in fourteen cities of mainland China, including Shanghai. Our study displayed the same results among the 27 MuH MRSA isolates representative (55.6%, 15/27). However, the ST5 isolates also accounted for 25.9% (7/27) of the representative strains ([Table 4](#pone-0037005-t004){ref-type="table"}). [Table 4](#pone-0037005-t004){ref-type="table"} showed that the ST239-*agr1* (44.4%, 12/27), ST5-*agr1* (22.2%, 6/27) and ST239-*agr2* (18.5%, 5/27) were the common lineages in the two regions' isolates.

For the determinants involved in toxin mediated disease, all the isolates from the two regions contained at least one gene of this group. However, there were 6 Shanghai strains and 4 Wenzhou isolates that did not carry any staphylococcal enterotoxin gene ([Table 4](#pone-0037005-t004){ref-type="table"}). [Table 4](#pone-0037005-t004){ref-type="table"} shows there were 3 Shanghai isolates lacking genes involved in tissue invasion/penetration and the 'others' group genes (*sarA* and *efb*). In addition, 1 Shanghai isolate and 1 Wenzhou isolate were only absent from the genes divided into the 'others' group. In Shanghai and Wenzhou strains hosting ≤2 genes involved in toxin mediated disease, most of them also carried fewer other virulence genes ([Table 4](#pone-0037005-t004){ref-type="table"}). In addition, Some MuH isolates yielded different virulence genes patterns even though they were of the same PFGE-SCC*mec*-*spa*-*agr*-ST type, and the same virulence determinants combination can belong to different genotype patterns ([Table 4](#pone-0037005-t004){ref-type="table"}). In respect to these results, the possible explanation may be that some virulence determinants are located on mobile genetic elements and can be horizontally transmitted among bacteria.

In summary, our study showed there were some differences in virulence profiles between MuH MRSA isolates from Shanghai and Wenzhou, and the differences mainly existed in the genes *sea*, *sec*, *seg*, *sei*, *tst*, *cna* and *pvl*. The results of MLST and *agr* typing displayed that the two regions' isolates were genetically less diverse.
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